Paritosh Pande

Associate Director Merck & Co

Dr. Paritosh Pande is an Associate Principal Scientist and technical lead in the Sterile Drug Product Commercialization group at Merck, West Point, PA, where he supports late-stage commercialization of biologics. He joined Merck in 2021 as an Associate Director to lead lyophilization platform technology for vaccine manufacturing and, since 2024, has focused on advancing ADC programs by evaluating key variables that impact the scalability of vial fogging across manufacturing sites. He is the lyo lead for Merck at BioPhorum Operations Group, active member of LyoHUB consortium and co-leads Merck’s
Lyophilization Community of Practice focused on promoting industry best practices for development, scale-up and technology transfer of parenteral injectable drug products.

Seminars

Wednesday 14th October 2026
Assessing Lyophilization Process Levers to Ensure Robust Process Strategy in ADC Drug Product Manufacturing
2:30 pm
  • Understanding the challenges to ensure consistent product quality in ADC lyophilization and DP manufacturing
  • Breaking down strategy to utilize lyophilization process levers to control factors across depyrogenation, nucleation and annealing
  • Laying out lessons for other ADC developers to approach lyophilization and DP manufacturing with confidence 
Paritosh Pande